Auteri Michelangelo, Zizzo Maria Grazia, Amato Antonella, Serio Rosa
Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Laboratorio di Fisiologia Generale, Università di Palermo, Viale delle Scienze, 90128, Palermo, Italy.
ATeN (Advanced Technologies Network) Center, Università di Palermo, Viale delle Scienze, Palermo, 90128, Italy.
J Physiol Biochem. 2016 Aug;73(3):395-404. doi: 10.1007/s13105-017-0566-0. Epub 2017 Jun 9.
Dopamine (DA) acts as gut motility modulator, via D1- and D2-like receptors, but its effective role is far from being clear. Since alterations of the dopaminergic system could lead to gastrointestinal dysfunctions, a characterization of the enteric dopaminergic system is mandatory. In this study, we investigated the role of DA and D1- and D2-like receptors in the contractility of the circular muscle of mouse distal colon by organ-bath technique. DA caused relaxation in carbachol-precontracted circular muscle strips, sensitive to domperidone, D2-like receptor antagonist, and mimicked by bromocriptine, D2-like receptor agonist. 7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH-23390), D1-like receptor antagonist, neural toxins, L-NAME (nitric oxide (NO) synthase inhibitor), 2'-deoxy-N-methyl adenosine 3',5'-diphosphate diammonium salt (MRS 2179), purinergic P2Y1 antagonist, or adrenergic antagonists were ineffective. DA also reduced the amplitude of neurally evoked cholinergic contractions. The effect was mimicked by (±)-1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrobromide (SKF-38393), D1-like receptor agonist and antagonized by SCH-23390, MRS 2179, or L-NAME. Western blotting analysis determined the expression of DA receptor proteins in mouse distal colon. Notably, SCH-23390 per se induced an increase in amplitude of spontaneous and neurally evoked cholinergic contractions, unaffected by neural blockers, L-NAME, MRS 2179, muscarinic, adrenergic, or D2-like receptor antagonists. Indeed, SCH-23390-induced effects were antagonized by an adenylyl cyclase blocker. In conclusion, DA inhibits colonic motility in mice via D2- and D1-like receptors, the latter reducing acetylcholine release from enteric neurons, involving nitrergic and purinergic systems. Whether constitutively active D1-like receptors, linked to adenylyl cyclase pathway, are involved in a tonic inhibitory control of colonic contractility is questioned.
多巴胺(DA)通过D1样和D2样受体发挥肠道运动调节剂的作用,但其确切作用尚不清楚。由于多巴胺能系统的改变可能导致胃肠功能障碍,因此对肠内多巴胺能系统进行特征描述很有必要。在本研究中,我们通过器官浴技术研究了DA以及D1样和D2样受体在小鼠远端结肠环行肌收缩性中的作用。DA可使卡巴胆碱预收缩的环行肌条松弛,该作用对多潘立酮(一种D2样受体拮抗剂)敏感,并可被溴隐亭(一种D2样受体激动剂)模拟。7-氯-8-羟基-3-甲基-1-苯基-2,3,4,5-四氢-1H-3-苯并氮杂卓盐酸盐(SCH-23390,一种D1样受体拮抗剂)、神经毒素、L- NAME(一氧化氮(NO)合酶抑制剂)、2'-脱氧-N-甲基腺苷3',5'-二磷酸二铵盐(MRS 2179,一种嘌呤能P2Y1拮抗剂)或肾上腺素能拮抗剂均无效。DA还降低了神经诱发的胆碱能收缩的幅度。该作用可被(±)-1-苯基-2,3,4,5-四氢-(1H)-3-苯并氮杂卓-7,8-二醇氢溴酸盐(SKF-38393,一种D1样受体激动剂)模拟,并被SCH-23390、MRS 2179或L-NAME拮抗。蛋白质免疫印迹分析确定了DA受体蛋白在小鼠远端结肠中的表达。值得注意的是,SCH-23390本身可诱导自发性和神经诱发的胆碱能收缩幅度增加,该作用不受神经阻滞剂、L-NAME、MRS 2179、毒蕈碱能、肾上腺素能或D2样受体拮抗剂的影响。实际上,SCH-23390诱导的作用可被一种腺苷酸环化酶阻滞剂拮抗。总之,DA通过D2样和D1样受体抑制小鼠结肠运动,后者可减少肠神经元释放乙酰胆碱,涉及氮能和嘌呤能系统。与腺苷酸环化酶途径相关的组成型活性D1样受体是否参与结肠收缩性的紧张性抑制控制仍有待探讨。